These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5335427)

  • 1. A study among African school-children of the repository antimalarial properties of cycloguanil pamoate, 4,4+-diacetyldiaminodiphenylsulfone, and a combination of the two drugs.
    Laing AB; Pringle G; Lane FC
    Am J Trop Med Hyg; 1966 Nov; 15(6):838-48. PubMed ID: 5335427
    [No Abstract]   [Full Text] [Related]  

  • 2. A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area of New Guinea.
    Rieckmann KH
    Am J Trop Med Hyg; 1966 Nov; 15(6):833-7. PubMed ID: 5335161
    [No Abstract]   [Full Text] [Related]  

  • 3. Field trial of cycloguanil pamoate in the treatment and suppression of malaria in Nigerian school children: a preliminary report.
    Fasan PO
    Trans R Soc Trop Med Hyg; 1970; 64(6):839-49. PubMed ID: 5495634
    [No Abstract]   [Full Text] [Related]  

  • 4. Field trials of repository antimalarial compounds.
    Clyde DF
    J Trop Med Hyg; 1969 Apr; 72(4):81-5. PubMed ID: 4890149
    [No Abstract]   [Full Text] [Related]  

  • 5. A trial of CI-564 (dapolar), a repository antimalarial for prophylaxis in Amapá, Brazil.
    Gusmão HH; Juarez E
    Am J Trop Med Hyg; 1970 May; 19(3):394-400. PubMed ID: 4911012
    [No Abstract]   [Full Text] [Related]  

  • 6. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 7. The repository antimalarial activities of 4,4'-diacetylaminodiphenylsulfone and cycloguanil pamoate (Cl-501) in monkeys relative to local release following parenteral administration.
    Thompson PE; Waitz JA; Olszewski B
    J Parasitol; 1965 Jun; 51(3):345-9. PubMed ID: 4953989
    [No Abstract]   [Full Text] [Related]  

  • 8. ANTIMALARIAL EFFECT OF SULPHORTHODIMETHOXINE (FANASIL).
    LAING AB
    Br Med J; 1964 Dec; 2(5422):1439-40. PubMed ID: 14209369
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of cutaneous leishmaniasis in Iraq with cycloguanil pamoate.
    Salem HH; Elkomy HM; el-Allaf G
    Trans R Soc Trop Med Hyg; 1969; 63(3):388-92. PubMed ID: 5795162
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the antimalarial activity of dihydrotriazine pamoate C. I. Camolar].
    Payet M; Pène P; Michel R; Sankalé M; Bernou JC; Guèye I
    Bull Soc Med Afr Noire Lang Fr; 1966; 11(2):147-69. PubMed ID: 5914183
    [No Abstract]   [Full Text] [Related]  

  • 12. Taste-masked quinine pamoate tablets for treatment of children with uncomplicated Plasmodium falciparum malaria.
    Kayitare E; Vervaet C; Mehuys E; Kayumba PC; Ntawukulilyayo JD; Karema C; Bortel V; Remon JP
    Int J Pharm; 2010 Jun; 392(1-2):29-34. PubMed ID: 20230885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the antimalarial effects of cycloguanil pamoate (CI-501) in man.
    Powell RD; DeGowin RL; Eppes RB
    Am J Trop Med Hyg; 1965 Nov; 14(6):913-21. PubMed ID: 5320454
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance to cycloguanil pamoate (CI-501) by falciparum malaria in West Pakistan.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1965 Nov; 14(6):925-6. PubMed ID: 5320456
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
    Basco LK; Ramiliarisoa O; Le Bras J
    Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting, repository antimalarial agents. Duration of protection in mice and monkeys following administration of pyrimethamine pamoate.
    Werbel LM; Jacobs RL; Steinkampf RW; Worth DF
    Am J Trop Med Hyg; 1984 Jul; 33(4):526-33. PubMed ID: 6236702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cutaneous leishmaniasis (oriental sore) with a new repository antimalarial.
    Kurban AK; Malak JA; Farah FS; Siage J; Jallad M
    J Trop Med Hyg; 1969 Apr; 72(4):86-8. PubMed ID: 5769717
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of American dermal leishmaniasis with cycloguanil pamoate.
    Pena Chavarria A; Kotcher E; Lizano C
    Trans R Soc Trop Med Hyg; 1968; 62(4):550-5. PubMed ID: 5671542
    [No Abstract]   [Full Text] [Related]  

  • 19. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release of a dual antimalarial system.
    Wise DL; Gresser JD; McCormick GJ
    J Pharm Pharmacol; 1979 Apr; 31(4):201-4. PubMed ID: 36455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.